CS
Chirag Singhal's blog
General · 7 min read

Part 21: Pregabalin – The Neuropathic Pain Healer and the New Wave of Misuse

A comprehensive clinical and harm-reduction guide to Pregabalin in India, exploring its role in nerve pain and anxiety, its Jan Aushadhi pricing, the rising trend of its misuse as 'The New Tramadol,' and the April 2026 Schedule H1 update.

Part 21: Pregabalin – The Neuropathic Pain Healer and the New Wave of Misuse

Pregabalin: The Gabapentinoid Revolution

Pregabalin, famously branded as Lyrica and in India as Pregalin or Pregeb, was hailed as a breakthrough for the treatment of neuropathic pain and Generalized Anxiety Disorder (GAD). By targeting specific calcium channels in the nervous system, it provided relief for millions of Indians suffering from diabetic neuropathy and fibromyalgia. However, in the last few years, Pregabalin has emerged as one of the most frequently misused prescription drugs in the world, including in India. Its ability to produce a dissociative, euphoric “high” and its dangerous synergy with opioids have led to its recent classification as a high-risk substance in 2026.

This twenty-first installment begins our section on Gabapentinoids and provides an exhaustive analysis of Pregabalin in India for 2026.


1. Substance Profile & Classification

  • Generic Name: Pregabalin
  • Chemical Class: Gabapentinoid (Gamma-aminobutyric acid analogue)
  • Therapeutic Class: Anticonvulsant / Neuropathic Pain Agent / Anxiolytic
  • Indian Legal Status:
    • Schedule H1 Drug (2026 Update): Following the April 2026 recommendation of the Drugs Consultative Committee (DCC), Pregabalin has been moved from Schedule H to Schedule H1. This mandate requires pharmacists to maintain a separate sales register with patient and doctor details to prevent over-the-counter diversion.
    • Regulatory Scrutiny: This shift was triggered by the skyrocketing rates of Pregabalin-related deaths and its widespread use as a “street drug” in both urban and rural India.

2. Market Availability and Pricing in India (May 2026)

Pregabalin is widely available in India in strengths ranging from 50mg to 300mg, often in combination with B-vitamins or antidepressants.

A. PMBJP (Jan Aushadhi Kendra) Availability

The Jan Aushadhi initiative provides Pregabalin at a massive discount, making it a critical resource for diabetic patients with nerve pain.

Medicine NameUnit SizeJan Aushadhi Price (INR)
Pregabalin Capsules IP 75 mg10’s₹20.63
Pregabalin Tablets IP 150 mg10’s₹28.13
Pregabalin (75mg) + Methylcobalamin (750mcg)10’s₹35.63

B. Branded Market Prices (Commercial Sector)

Leading private brands remain expensive. As of May 2026, many brands have updated their labels to reflect the Schedule H1 re-classification.

Brand NameManufacturerStrengthApprox. Market Price (INR)
LyricaPfizer India75mg (14 Caps)₹945.00
PregalinTorrent Pharmaceuticals75mg (15 Caps)₹185.00
PregebTorrent Pharmaceuticals150mg (10 Caps)₹245.00
MaxgalinSun Pharma75mg (10 Caps)₹162.00
Nova-75Cipla Ltd.75mg (10 Caps)₹155.00
PregabidIntas Pharmaceuticals75mg (10 Caps)₹148.00

[!WARNING] The H1 Register: Pregabalin is now under Schedule H1. Every purchase is recorded in a special register with your Aadhaar or ID details. Pharmacies selling without this audit trail face immediate license cancellation in 2026.


3. Clinical Pharmacology: Beyond GABA

Mechanism of Action

Despite its name and structure, Pregabalin does not bind to GABA receptors.

  • The Voltage-Gated Calcium Channel (VGCC): Pregabalin binds to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system.
  • Neurotransmitter Suppression: By blocking these channels, it reduces the entry of calcium into nerve cells, which in turn stops the release of “excitatory” neurotransmitters like Glutamate, Substance P, and Norepinephrine.
  • Result: It effectively “numbs” overactive nerves, providing relief from chronic pain and quieting the hyper-active brain signals associated with anxiety.

Pharmacokinetics

  • Absorption: Rapid and nearly 90% complete.
  • Half-life: Approximately 6.3 hours.
  • Clearance: It is excreted entirely unchanged by the kidneys, making it safer for patients with liver disease but requiring dose adjustments for those with kidney issues.

4. Euphoria and Misuse: “The New Tramadol”

Euphoria Profile

  • The “Floaty” High: Misusers describe the Pregabalin high as a mix of relaxation, mild dissociation (feeling “disconnected” from the body), and a unique sense of social confidence.
  • The “Budweiser” Effect: In some Indian circles, a 300mg dose of Pregabalin is colloquially compared to the feeling of drinking several beers without the smell or the stomach upset.

The Opioid Synergy (The Deadly Mix)

The most dangerous trend in 2026 is the combination of Pregabalin and Opioids (like Tapentadol or Heroin).

  • Overdose Potentiation: Pregabalin exponentially increases the respiratory depression caused by opioids. Research shows that users taking both are 3 times more likely to die of an overdose than those taking opioids alone.

  1. Gym Culture: There is a rising trend of using Pregabalin in Indian fitness circles to manage the pain of overtraining, leading to accidental addiction.
  2. Youth Diversion: Because it was relatively easy to obtain until recently, Pregabalin became a popular “party drug” for those wanting to avoid the social stigma of alcohol.
  3. Self-Medication for GAD: Many individuals with undiagnosed anxiety in India self-medicate with Pregabalin, unaware that it requires a strict medical taper to stop.

6. Critical Risks: Weight Gain and Seizures

  • Metabolic Impact: Weight gain is a very common side effect in Indian patients, often leading to poor compliance.
  • The Seizure Paradox: While used to treat epilepsy, taking massive doses for misuse or stopping the drug suddenly can actually cause life-threatening seizures.

7. Toxicity and Overdose

Overdose Signs

  • Ataxia (Staggering like a drunk person).
  • Diplopia (Double vision).
  • Profound Sedation.
  • Myoclonus (Sudden muscle jerks).

Emergency Action: Call 14446. There is no specific antidote for Pregabalin. Treatment in hospitals involves gastric lavage (if caught early) and intensive supportive care.


  • Schedule H1 Non-Compliance: Any pharmacy found selling Pregabalin without an H1 Register entry now faces immediate license suspension under the 2026 DCC rules.
  • Illicit Trade: The Indian Narcotics Control Bureau (NCB) has designated Pregabalin as a “Substance of Concern,” leading to increased border checks for illicit manufacturing.

9. Addiction and Recovery

Pregabalin withdrawal is notoriously difficult and can last for weeks.

  • Symptoms: Insomnia, nausea, headache, anxiety, sweating, and severe “electric shock” sensations in the limbs.
  • Recovery: Requires a very slow taper (often 10-25% reduction every 2 weeks) and specialized psychological support to manage the “rebound” anxiety.

Resources for Help in India

  • National Drug De-addiction Helpline: 14446
  • PGI Chandigarh: (Specialized clinic for Gabapentinoid misuse).
  • NIMHANS: Bangalore.

10. Harm Reduction Strategies

  • The Kidney Rule: If you have any history of kidney problems, your Pregabalin dose must be halved. Using standard doses with poor kidney function can lead to rapid toxicity.
  • No Alcohol/Opioids: Never mix Pregabalin with other depressants. The risk of respiratory arrest is unpredictable and high.
  • The “Slow Stop”: Never stop taking Pregabalin “Cold Turkey.” The risk of rebound anxiety and seizures is severe.

Next in the Series: Part 22: Gabapentin – The Original Gabapentinoid and the Nerve Pain Foundation

Disclaimer: This series is for educational and harm-reduction purposes only. Pregabalin is a highly potent medication that requires a strict medical prescription. Misuse can lead to fatal respiratory depression and severe addiction.

Share:
Bookmark

Comments

Related Posts